 |
Previous Article | Next Article 
Volume 17, Number 16,
Issue of August 15, 1997
pp. 6114-6121
Copyright ©1997 Society for Neuroscience
Apolipoprotein E Binds to and Potentiates the Biological Activity
of Ciliary Neurotrophic Factor
Received Jan. 8, 1997; revised May 30, 1997; accepted June 4, 1997.
Catherine R. Gutman1,
Warren J. Strittmatter1, 2,
Karl H. Weisgraber3, and
William D. Matthew1
Departments of 1 Neurobiology and
2 Medicine (Neurology) and Joseph and Kathleen Bryan
Alzheimer's Disease Research Center, Duke University Medical Center,
Durham, North Carolina 27710, and 3 Gladstone Institute of
Cardiovascular Disease, Cardiovascular Research Institute, Department
of Pathology, University of California, San Francisco, California
94140
Expression of apolipoprotein E (apoE) and ciliary neurotrophic
factor (CNTF), a pleiotropic neuron survival factor, increases in the
CNS in response to injury. Although CNTF is believed to act as a
survival factor after injury in the CNS, the functions of apoE in the
CNS remain mainly unknown. Similarities between apoE and CNTF,
including coinciding patterns of postinjury expression, extracellular
localization, homologous tertiary structure, and ability to form
homodimers led us to examine the possibility that apoE and CNTF
directly associate and thereby facilitate the neurotrophic activity of
CNTF. We identified two binding interactions between apoE and CNTF: (1)
reversible binding of both the apoE3 and apoE4 isoforms to CNTF under
nondenaturing conditions, and (2) a higher avidity, SDS-stable binding
of apoE3 with CNTF. Purified lipid-free apoE, as well as apoE in
cerebrospinal fluid, binds CNTF. We demonstrate here that the
survival-promoting activity of CNTF on cultured hippocampal neurons is
potentiated by apoE. In the absence of apoE, survival of hippocampal
neurons with 1 ng/ml CNTF was 20% above control survival values. In
contrast, in the presence of apoE, survival of hippocampal neurons with
1 ng/ml CNTF was 40% above control survival values. These data, which
indicate a novel function for apoE in the nervous system, support the
hypothesis that apoE secreted locally at sites of injury can facilitate
neural repair by promoting the activity of certain growth factors, in particular CNTF.
Key words:
apoE;
CNTF;
neuron survival;
protein binding;
cytokine;
hippocampal neurons
This article has been cited by other articles:

|
 |

|
 |
 
L. Shen, P. Tso, S. C. Woods, D. J. Clegg, K. L. Barber, K. Carey, and M. Liu
Brain Apolipoprotein E: an Important Regulator of Food Intake in Rats
Diabetes,
August 1, 2008;
57(8):
2092 - 2098.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F.-Q. Li, G. D. Sempowski, S. E. McKenna, D. T. Laskowitz, C. A. Colton, and M. P. Vitek
Apolipoprotein E-Derived Peptides Ameliorate Clinical Disability and Inflammatory Infiltrates into the Spinal Cord in a Murine Model of Multiple Sclerosis
J. Pharmacol. Exp. Ther.,
September 1, 2006;
318(3):
956 - 965.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Qin, C. Colin, I. Hinners, A. Gervais, C. Cheret, and M. Mallat
System Xc- and apolipoprotein E expressed by microglia have opposite effects on the neurotoxicity of amyloid-beta peptide 1-40.
J. Neurosci.,
March 22, 2006;
26(12):
3345 - 3356.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D O'Toole and W C Love
Interferon-{beta}-1b and interferon-{gamma} have similar inhibitory effects on apolipoprotein-E production in the monocyte/macrophage
Multiple Sclerosis,
April 1, 2002;
8(2):
124 - 129.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Chapman, S. Vinokurov, A. Achiron, D. M. Karussis, K. Mitosek-Szewczyk, M. Birnbaum, D. M. Michaelson, and A. D. Korczyn
APOE genotype is a major predictor of long-term progression of disability in MS
Neurology,
February 13, 2001;
56(3):
312 - 316.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. S. Bedlack, W. J. Strittmatter, and J. C. Morgenlander
Apolipoprotein E and Neuromuscular Disease: A Critical Review of the Literature
Arch Neurol,
November 1, 2000;
57(11):
1561 - 1565.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Chapman, C. Sylantiev, P. Nisipeanu, and A. D. Korczyn
Preliminary Observations on APOE{epsilon}4 Allele and Progression of Disability in Multiple Sclerosis
Arch Neurol,
December 1, 1999;
56(12):
1484 - 1487.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Spiro, M. B. Dalva, and R. Mooney
Long-Range Inhibition Within the Zebra Finch Song Nucleus RA Can Coordinate the Firing of Multiple Projection Neurons
J Neurophysiol,
June 1, 1999;
81(6):
3007 - 3020.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. S. Montine, C. N. Bassett, J. J. Ou, W. R. Markesbery, L. L. Swift, and T. J. Montine
Apolipoprotein E allelic influence on human cerebrospinal fluid apolipoproteins
J. Lipid Res.,
December 1, 1998;
39(12):
2443 - 2451.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
Y. Sun, S. Wu, G. Bu, M. K. Onifade, S. N. Patel, M. J. LaDu, A. M. Fagan, and D. M. Holtzman
Glial Fibrillary Acidic Protein-Apolipoprotein E (apoE) Transgenic Mice: Astrocyte-Specific Expression and Differing Biological Effects of Astrocyte-Secreted apoE3 and apoE4 Lipoproteins
J. Neurosci.,
May 1, 1998;
18(9):
3261 - 3272.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. A. Kukull and G. M. Martin
APOE Polymorphisms and Late-Onset Alzheimer Disease: The Importance of Ethnicity
JAMA,
March 11, 1998;
279(10):
788 - 789.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Jordan, M. F. Galindo, R. J. Miller, C. A. Reardon, G. S. Getz, and M. J. LaDu
Isoform-Specific Effect of Apolipoprotein E on Cell Survival and beta -Amyloid-Induced Toxicity in Rat Hippocampal Pyramidal Neuronal Cultures
J. Neurosci.,
January 1, 1998;
18(1):
195 - 204.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|